XENE
Xenon Pharmaceuticals Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−1.84%
vs ±9.1% implied · ×0.20
shaded = implied · ▲▼ = realized
No thesis.
Xenon Pharmaceuticals Inc.
37.42
−0.12 · −0.32%
post 37.86 +1.18%
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $582.4M | 9.45% | −10.82% | |
| 2 | BlackRockBlackRockindex-like | $454.1M | 7.37% | +33.37% | |
| 3 | venBio Select AdvisorvenBio Select Advisor | $348.7M | 5.66% | 0.00% | |
| 4 | Polar Capital HoldingsPolar Capital | $275.9M | 4.48% | +3.75% | |
| 5 | Driehaus Capital ManagementDriehaus | $266.7M | 4.33% | −1.63% | |
| 6 | Jupiter TopcoJupiter Topco | $252.7M | 4.10% | — | |
| 7 | T. Rowe Price AssociatesT. Rowe Price | $196.1M | 3.18% | +144.30% | |
| 8 | JPMorgan ChaseJPMorgan Chase | $157.4M | 2.55% | +36.07% | |
| 9 | Capital International InvestorsCapital International Investors | $142.5M | 2.31% | −11.71% | |
| 10 | T. Rowe Price Investment ManagementT. Rowe Price | $130.9M | 2.12% | +127.80% | |
| 11 | State StreetState Streetindex-like | $118.9M | 1.93% | +14.48% | |
| 12 | Two Sigma InvestmentsTwo Sigma | $99.2M | 1.61% | +171.06% | |
| 13 | Deerfield ManagementDeerfield | $97.5M | 1.58% | 0.00% | |
| 14 | Affinity Asset AdvisorsAffinity Asset | $96.3M | 1.56% | −4.78% | |
| 15 | Westfield Capital ManagementWestfield | $91.0M | 1.48% | +7.55% | |
| 16 | AlliancebernsteinAlliancebernstein | $90.8M | 1.47% | +11.33% | |
| 17 | Citadel AdvisorsCitadel | $87.4M | 1.42% | −49.83% | |
| 18 | Franklin ResourcesFranklin Resources | $86.8M | 1.41% | +12.27% | |
| 19 | Wellington Management GroupWellington | $86.0M | 1.40% | −70.48% | |
| 20 | Geode Capital ManagementGeodeindex-like | $82.7M | 1.34% | +25.36% | |
| 21 | SirenSiren | $79.6M | 1.29% | 0.00% | |
| 22 | BNP Paribas Investment PartnersBNP Paribas Investment Partners | $77.9M | 1.26% | −3.82% | |
| 23 | Pictet Asset Management HoldingPictet | $71.6M | 1.16% | +74.74% | |
| 24 | BraidwellBraidwell | $68.3M | 1.11% | −15.47% | |
| 25 | NuveenNuveenindex-like | $59.9M | 0.97% | +297.19% |
316 managers report $6.2B of Xenon Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 44 of them hold 80% of it; FMR is largest at 9.45%.
Linked news
Expected move
Inputs8Q avg ±5.1%·×1.08·fair
straddle ±9.8%
spot 37.41exp Nov 20ATM strike 37.5ATM straddle 4.30IV 60%